Abstract
Treatment of spasticity, dystonia, and rigidity has dramatically changed since the introduction of intrathecal baclofen. Before the advent of intrathecal baclofen, the toxicity and side effect profiles of oral antispasticity medications limited most patients from receiving therapeutic dosages of these medications, and Botox treatments have not been a long-term solution for medically refractory spasticity. Over the course of the past 30years, intrathecal administration of baclofen has revolutionized the treatment of patients suffering from spasticity due to a wide range of underlying etiologies. For the surgeon implanting intrathecal drug delivery systems, proper planning and technique coupled with the ability to manage not only the surgical but also the medication-related complications of intrathecal baclofen ensures that the patient will have the optimal clinical outcome. In this chapter, we describe and discuss the indications, techniques, and some of the possible complications associated with implantation and management of intrathecal baclofen pumps and catheters.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
